Abcellera biologics’s upcoming earnings report date is may 08, 2024 which is in 34 days. View abcellera biologics (nasdaq:abcl) historical prices, past price performance, and an advanced abcl stock chart at marketbeat.
Shares Of Abcellera Biologics Inc.
Since then, abcl shares have decreased by 32.6% and is now.
I Still Expect Abcellera Stock To Lose Some Value In 2024 As It Gets To Grips With A Changing Business Model, But With ≫$850M Cash To Spend, The Company Can Afford To Take The.
Abcellera biologics’ stock was trading at $5.71 on january 1st, 2024.
Abcl ) Stock Is To Strong.
Images References :
The Consensus Among 2 Wall Street Analysts Covering ( Nasdaq :
I still expect abcellera stock to lose some value in 2024 as it gets to grips with a changing business model, but with >$850m cash to spend, the company can afford to take the.
The Forecasts Range From A Low Of $8.00 To A.
→ the asset beating inflation by 4x (from colonial metals) abcellera biologics inc.
Research Abcellera Biologics' (Nasdaq:abcl) Stock Price, Latest News &Amp; Stock Analysis.